As supplies of COVID-19 vaccines have become more plentiful in poor nations, many are tuning down certain shipments.
A document from the World Health Organization’s global vaccine supply effort COVAX shows that low-income countries have declined millions of doses of AstraZeneca’s Vaxzevria, Reuters reports.
Since the relief initiative began, AstraZeneca has been its most prolific supplier. But that’s changing quickly. Of 200 million COVAX doses assigned to 61 lower-income countries during a six-month period that will end in September, only a small portion will be from AZ.